A clinical trial testing the intrarectal delivery of perfluorodecalin in 27 volunteers showed that the procedure was safe and feasible, with only minimal adverse effects reported. A first-in-human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results